PJ
Co-Founder & Strategic Advisor
Get the full picture
Sign in to uncover key details.
PathomIQ
Healthcare Software · California, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
19925 Stevens Creek Blvd Ste 100, Cupert...Website
www.pathomiq.comRevenue
<$5 MillionIndustry
About PathomIQ
PATHOMIQ is a pioneering company that leverages an AI-driven platform to enhance precision medicine in oncology. Their innovative technology integrates morphology and genomics to predict treatment responses for prostate, breast, and bladder cancers, enabling personalized treatment plans based on individual genomic profiles. The platform is designed for healthcare professionals, providing rapid, cost-effective, and accurate predictions while preserving tissue integrity for advanced analysis. PATHOMIQ aims to transform cancer treatment by delivering interpretable insights that improve patient outcomes and reduce side effects.Explore more
PathomIQ Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Compare Similar Companies to PathomIQ
Compare insights from companies similar to PathomIQ, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
PathomIQ Tech Stack
A closer look at the technologies used by PathomIQ
Top Healthcare Software Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding PathomIQ
Sign Up For FreeTo access detailed company insights
PATHOMIQ is a pioneering company that leverages an AI-driven platform to enhance precision medicine in oncology. Their innovative technology integrates morphology and genomics to predict treatment responses for prostate, breast, and bladder cancers, enabling personalized treatment plans based on individual genomic profiles. The platform is designed... Read More
